These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15183644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J.
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The schizophrenic career of a "monster drug".
    Crawford CL.
    Pediatrics; 2003 Mar; 111(3):712. PubMed ID: 12612270
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thalidomide in the treatment of leprosy.
    Teo S, Resztak KE, Scheffler MA, Kook KA, Zeldis JB, Stirling DI, Thomas SD.
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [Abstract] [Full Text] [Related]

  • 10. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
    Hebe Petiti-Martin G, Villar-Buill M, de la Hera I, Fuertes L, Burgués-Calderón M, Rivera-Díaz R, Vanaclocha F.
    Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
    [Abstract] [Full Text] [Related]

  • 11. From the Food and Drug Administration.
    Nightingale SL.
    JAMA; 1998 Sep 09; 280(10):872. PubMed ID: 9739956
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral edema in lepromatous leprosy--could thalidomide be the culprit.
    Mehta V.
    Indian J Lepr; 2008 Sep 09; 80(4):345-6. PubMed ID: 20329383
    [No Abstract] [Full Text] [Related]

  • 14. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B, Pallapati MS, Tarwater P, Srikantam A.
    PLoS Negl Trop Dis; 2020 Oct 09; 14(10):e0008678. PubMed ID: 33035210
    [Abstract] [Full Text] [Related]

  • 15. The management of erythema nodosum leprosum: current and future options.
    Lockwood DN.
    Lepr Rev; 1996 Dec 09; 67(4):253-9. PubMed ID: 9033196
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathologic challenge.
    Kawakami T, Tsutsumi Y, Mizoguchi M, Ishi N, Soma Y.
    Int J Dermatol; 2007 Apr 09; 46(4):348-9. PubMed ID: 17442070
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP.
    J Drugs Dermatol; 2009 Aug 09; 8(8):765-9. PubMed ID: 19663116
    [Abstract] [Full Text] [Related]

  • 18. [Thalidomide: new uses for an old drug].
    Wu KL, Sonneveld P.
    Ned Tijdschr Geneeskd; 2002 Aug 03; 146(31):1438-41. PubMed ID: 12190008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B.
    Int J Lepr Other Mycobact Dis; 1996 Dec 03; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.